CJC-1295 Ipamorelin: Benefits, Dosage & DAC vs No-DAC
Evidence and status Approval status Not FDA approved Strongest support Limited human research Route context Human studies and reported practice; no approved route Competitive sport Prohibited in sport Lab work Animal studies Human studies Approved label CJC-12
Approval status Not FDA approved
Strongest support Limited human research
Route context Human studies and reported practice; no approved route
Competitive sport Prohibited in sport
Lab work
Animal studies
Human studies
Approved label
CJC-1295 is studied for body composition, recovery, and sleep through growth hormone signaling. Its DAC, or Drug Affinity Complex, lets the peptide bind to albumin and remain active longer. The no-DAC version is shorter acting. Both are often paired with ipamorelin.
Get the Free Peptide Tracking Toolkit
CJC-1295 + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
What is CJC-1295?
CJC-1295 is a modified peptide based on the first 29 amino acids of growth-hormone-releasing hormone — the sequence that carries GHRH's biological activity.
The modifications make it more stable than natural GHRH, which is broken down in the body within minutes. By mimicking GHRH, CJC-1295 prompts the pituitary to secrete growth hormone in a natural, pulsatile pattern rather than flooding the body with synthetic GH.
DAC vs non-DAC (Mod GRF 1-29)
The single most important distinction with CJC-1295 is whether it carries DAC:
- CJC-1295 with DAC. DAC (Drug Affinity Complex) binds to albumin in the bloodstream, which dramatically extends the peptide's half-life. The result is a sustained elevation of GH and IGF-1 over several days from a single dose, dosed roughly once or twice weekly.
- CJC-1295 without DAC (Mod GRF 1-29). Without the DAC group, the peptide is short-acting — it clears within a few hours and produces a sharp, brief GH pulse. It is dosed more frequently, typically alongside a meal-timed protocol.
The form used in a protocol changes the dosing schedule and stack design. Confirm the exact form with the prescribing provider.
The naming can be confusing. CJC-1295 originally refers to the long-acting DAC compound. Products sold as “CJC-1295 no DAC” are generally Mod GRF 1-29, a related short-acting GHRH analog rather than the same molecule with one ingredient removed.
Benefits and uses
People use CJC-1295 for several goals connected with growth hormone and IGF-1:
- Body composition. Users discuss CJC-1295 for lean-mass and fat-loss goals because it raises GH and IGF-1.
- Recovery. People training hard report using it to support recovery between sessions.
- Sleep. Growth hormone is released in the deepest stages of sleep; users report improved sleep quality on GHRH-analog protocols.
- Healthy-aging goals. Interest comes from the age-related decline in GH and IGF-1 and from users tracking those levels over time.
A controlled study in healthy adults measured sustained increases in GH and IGF-1 after CJC-1295 with DAC. Most downstream body-composition, sleep, recovery, and healthy-aging outcomes come from reported use rather than large clinical trials.
The ipamorelin pairing
CJC-1295 is frequently paired with ipamorelin. The rationale combines two different growth-hormone signals.
CJC-1295 acts at the GHRH receptor, while ipamorelin acts at the ghrelin receptor. Clinics and users describe the pairing as a way to create a stronger pulse. Direct trials have not established the best combined regimen or its long-term outcomes.
The CJC-1295 and ipamorelin stack guide covers daily blend terminology, reported timing, reconstitution, and combined monitoring questions.
For a broader protocol, compare the stack with other muscle and performance peptides, and see sermorelin for the shorter-acting GHRH alternative.
How it works
CJC-1295 binds the GHRH receptor on the pituitary and stimulates the synthesis and release of growth hormone. The released GH acts on the liver and other tissues to produce IGF-1, the insulin-like growth factor that mediates most of GH's anabolic and repair effects.
Because the signal goes through the body's own pituitary, GH is released in pulses rather than as a constant synthetic level — the appeal over direct GH injection.
Biology and chemistry details
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is based on the biologically active region of GHRH and modified to resist rapid breakdown, which is why it lasts longer than natural GHRH.
The DAC version uses a Drug Affinity Complex that binds albumin and extends half-life for a sustained GH and IGF-1 signal. The non-DAC version is commonly called Mod GRF 1-29; it produces a shorter GH pulse and is usually discussed separately from CJC-1295 with DAC.
Dosage and administration
CJC-1295 is given by subcutaneous injection. Dosing depends entirely on the form: the DAC version is dosed roughly once or twice weekly because of its extended half-life, while the non-DAC version (Mod GRF 1-29) is dosed more frequently, often before bed or post-workout, to align with natural GH pulses.
It is commonly combined with ipamorelin in a single injection. These are not official dosing guidelines — there is no FDA-approved CJC-1295 product — and dosing should be set by the prescribing provider.
Reconstitution and drawing the right volume on an insulin syringe is where most errors happen. Use the peptide dosage calculator to convert a prescribed target dose into syringe units for the vial size.
Side effects and safety
Users report injection-site reactions, flushing, headache, and water retention. Controlled studies also recorded transient injection-site reactions and flushing.
Because it raises GH and IGF-1, the relevant monitoring is for the effects of higher GH: blood sugar can rise, and IGF-1 should be kept within a sensible range rather than pushed indefinitely.
Long-term human safety data for CJC-1295 specifically is limited. Anyone using it should monitor IGF-1 and metabolic markers and work with a provider.
Legal status and how to get CJC-1295
CJC-1295 was not among the 12 peptides removed from the FDA's Section 503A Category 2 list in April 2026. The July advisory committee did not consider it. Its compounding status remains more constrained than the reclassified peptides.
If prescribed after evaluation by a licensed provider, CJC-1295 should come from an appropriate pharmacy. Products sold online "for research use only" are not approved, manufactured, or quality-controlled for human use, and buying them carries quality and legal risk.
Get the Free Peptide Tracking Toolkit
CJC-1295 + many more
Explore the guide, then keep the details you verify in the Excel workbook.
Excel workbook
11 worksheets for vials, schedules, labs, storage, and more.
PDF guide
Review providers, products, documents, storage, and travel.
Free download
Useful before or after you start
- Before you start, compare the details that matter and build a focused question list.
- Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
- Separate your schedule from what actually happened, so important dates are easier to spot.
- Keep your private working copy on your own device.
Confirm your email to receive both downloads and your personal 20% off coupon.
Almost done
We sent the first email to .
Confirm your email to get the toolkit and your 20% off coupon.
We also sent a verification text. Reply YES to confirm your phone number.
-
1
Confirm your email
Open the first email and click the confirmation link.
-
2
Only after step 1
Then the toolkit arrives
We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.
The first email should arrive within a minute. Do not see it? Check spam or promotions.
Tell us where to send it
Free, no spam, only peptide news that matters. Unsubscribe anytime.
Blood work to track CJC-1295
CJC-1295 works by raising GH and IGF-1, so those are the direct readouts of whether it's doing anything:
- IGF-1 — the primary marker for any GH-releasing peptide. It should rise if CJC-1295 is working and can help identify excessive GH exposure.
- Human Growth Hormone — a direct GH measure that complements IGF-1.
Test at baseline and again at 4–8 weeks.
CJC-1295 and other growth-hormone-releasing factors are prohibited by WADA at all times.
Peptide Baseline Measurement Panel
Get your baseline
- No doctor visit required
- 2,200+ Quest locations
- Results in 1–2 business days
Get your baseline
References
- Teichman et al.: controlled CJC-1295 GH and IGF-1 study
- FDA December 2024 CJC-1295 advisory committee minutes
- WADA 2026 Prohibited List
Banned in competitive sport. This peptide is prohibited by the World Anti-Doping Agency (WADA), and athletes subject to drug testing can face sanctions for using it. Check current WADA and league rules before considering it.
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.